New York State Common Retirement Fund Gt Biopharma, Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.64 - $3.11 $13,120 - $24,880	-8,000 Reduced 98.0%	163 $0
Q1 2022 May 05, 2022	BUY	$2.6 - $3.3 $36 - $46	14 Added 0.17%	8,163 $24,000
Q4 2021 Feb 02, 2022	SELL	$3.05 - $7.08 $247 - $573	-81 Reduced 0.98%	8,149 $25,000
Q3 2021 Nov 02, 2021	SELL	$6.68 - $15.26 $81,295 - $185,714	-12,170 Reduced 59.66%	8,230 $55,000
Q2 2021 Aug 02, 2021	BUY	$7.19 - $18.96 $146,676 - $386,784	20,400 New	20,400 $316,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $96.4M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.